WVP
MIRM icon

Worth Venture Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Worth Venture Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-77,515
Closed -$1.24M – 156
2021
Q4 		$1.24M Buy
+77,515
New +$1.21M 0.61% 49
2021
Q1 		– Sell
-16,420
Closed -$287K – 125
2020
Q4 		$287K Sell
16,420
-34,456
-68% -$677K 0.23% 73
2020
Q3 		$980K Sell
50,876
-2,275
-4% -$48.8K 0.8% 32
2020
Q2 		$1.03M Sell
53,151
-761
-1% -$12.7K 0.51% 31
2020
Q1 		$755K Buy
53,912
+26,764
+99% +$439K 0.46% 35
2019
Q4 		$666K Buy
+27,148
New +$289K 0.33% 38

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Worth Venture Partners's MIRM Position: Q1 2022 in Review

Worth Venture Partners sold out of Mirum Pharmaceuticals (MIRM) in Q1 2022, closing a stake of 77,515 shares — an estimated $1.24M sold.

Worth Venture Partners first reported a position in MIRM in Q4 2019 and held it in 6 quarters. The position peaked at $1.24M in Q4 2021. 99 funds tracked by Wall St. Rank hold MIRM as of Q1 2022.

  • Worth Venture Partners reported no remaining Mirum Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Worth Venture Partners sold 77,515 Mirum Pharmaceuticals shares in Q1 2022, an estimated $1.24M.
  • Worth Venture Partners first reported a position in Mirum Pharmaceuticals in Q4 2019 and held it in 6 quarters.
  • Worth Venture Partners's Mirum Pharmaceuticals position peaked at $1.24M in Q4 2021.
  • 99 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2022.

Based on Worth Venture Partners's 13F filing for Q1 2022, filed 16 May 2022.